Go to deals
Healthcare

Aleris has sold its primary care operations to Lideta Hälsovård AB

As part of the ongoing strategic effort to specialize its Swedish healthcare business, Aleris divests its primary care business to Lideta Hälsovård AB (Lideta), a subsidiary of Nordstjernan.

Aleris is one of Scandinavia’s leading private and healthcare service providers, offering a wide range of services, including primary and specialist care, diagnostics, elderly, and psychiatric care for youth and adults. Aleris Primary Care consist of eleven of Aleris’ units providing care services within primary care and physical therapy for some 110,000 listed patients in Stockholm and Uppsala regions.

Lideta is a healthcare company within primary, maternity and child care as well as occupational healthcare in Stockholm and southern Sweden. Nordstjernan is its main owner and has the ambition to build a long-term, high-quality Swedish care provider. Lideta includes the healthcare group Mama Mia, Scandinavia's single largest private maternity care center located in Stockholm and Skåne. Mama Mia's activities also include gynecology, contraception counseling, ultrasound, as well as child and adolescent medical practices.

Patricia Industries is responsible for the wholly owned subsidiaries of Investor AB. Patricia Industries builds and develops companies with long-term growth potential in the Nordics and North America with strong customer relationships, brands and organizations.

Oaklins’ team in Sweden advised the seller in this carve-out divestment. The deal is another example of Oaklins Sweden’s strong presence within the local healthcare market.

Service
M&A sell-side
Parties

Talk to the deal team

 Sven-Åke  Lewin

Sven-Åke Lewin

Partner

Stockholm, Sweden
Oaklins Sweden
 Lars  Gustafsson

Lars Gustafsson

Partner

Stockholm, Sweden
Oaklins Sweden

Related deals

Global Media Santé has been acquired by SFP Expansion
Private Equity | Healthcare | TMT

Global Media Santé has been acquired by SFP Expansion

Global Media Santé’s CEO, Alain Trébucq, and Apax Partners have sold the company to SFP Expansion Group.

Learn more
Synairgen has successfully raised US$114 million to support phase III trial of COVID candidate
Healthcare

Synairgen has successfully raised US$114 million to support phase III trial of COVID candidate

Synairgen plc has completed its oversubscribed equity fundraising to raise US$114 million to fund a phase III trial for 900 patients for the effects of its SNG001 drug on patients with COVID-19. In addition, the raise will be used to scale up manufacturing and device activities.

Learn more
Westminster Homecare has been acquired by Care at Home
Healthcare

Westminster Homecare has been acquired by Care at Home

The private shareholders of Westminster Homecare Ltd. have sold the company to Care at Home Services (South East) Ltd.

Learn more